Kisker lab: 5B5Q: Difference between revisions
Line 30: | Line 30: | ||
Before you look at the details of the active site, you probably will want to show the overall view of Cdub1 again: <scene name='78/781027/Panela/3'>Panel A</scene>. | Before you look at the details of the active site, you probably will want to show the overall view of Cdub1 again: <scene name='78/781027/Panela/3'>Panel A</scene>. | ||
<scene name='78/781027/Paneld/3'>Panel D:</scene> The active site residues Cys 345, His, and Asp form the catalytic triad. Instead of showing omit density like in the paper, we are showing 2Fo-Fc <jmol><jmollink><text>density</text><script>isosurface "http://proteopedia.org/wiki/images/6/61/Map.jvxl" mesh; zoom *2</script></jmollink></jmol> | <scene name='78/781027/Paneld/3'>Panel D:</scene> The active site residues Cys 345, His, and Asp form the catalytic triad. Instead of showing omit density like in the paper, we are showing 2Fo-Fc <jmol><jmollink><text>density</text><script>isosurface "http://proteopedia.org/wiki/images/6/61/Map.jvxl" mesh; zoom *2; select 292 and sidechain; center selected</script></jmollink></jmol> | ||
<scene name='78/781027/Bonus/5'>Bonus figure:</scene> The active-site cysteine sidechain acting as a nucleophile in the hydrolysis reaction is buried surprisingly deeply, barely visible in the surface view (yellow). The alpha helix inserted between strand 1 and two (shown in yellow) is above the substrate binding cavity, with Val 271 blocking access to the active site. A all-atom view of the <scene name='78/781027/Panelf/1'>active site</scene> (catalytic triad in yellow, blue, red for Cys, His, Asp, respectively, with hydrophobic side chains in black) shows how inaccessible the active site cysteine is. Same as <scene name='78/781027/Panelf/2'>surface</scene>. | <scene name='78/781027/Bonus/5'>Bonus figure:</scene> The active-site cysteine sidechain acting as a nucleophile in the hydrolysis reaction is buried surprisingly deeply, barely visible in the surface view (yellow). The alpha helix inserted between strand 1 and two (shown in yellow) is above the substrate binding cavity, with Val 271 blocking access to the active site. A all-atom view of the <scene name='78/781027/Panelf/1'>active site</scene> (catalytic triad in yellow, blue, red for Cys, His, Asp, respectively, with hydrophobic side chains in black) shows how inaccessible the active site cysteine is. Same as <scene name='78/781027/Panelf/2'>surface</scene>. |
Revision as of 23:16, 16 March 2018
How this page was createdHow this page was created
The goal of this page is to make the figures found in the primary citation of the 5B5Q structure three-dimensional and interactive. The figures are closely modeled on Figure 2 panels A-E of the paper. Biochemistry students from Westfield State University have made drafts of the figures, and will revise them after getting feedback from the researchers working on this protein.
Chlamydia inhibits apoptosisChlamydia inhibits apoptosis
Chlamydia reproduces inside human cells. One defense of the human body against Chlamydia is to kill affected cells before Chlamydia reproduces. This is done through a process called apoptosis, programmed cell death. One player in apoptosis is the human protein Mcl-1. High Mcl-1 levels inhibit one of the signalling pathways that lead to apoptosis. Chlamydia inhibits Mcl-1 degradation so that Mcl-1 levels remain high.
Protein ubiquitination and degradationProtein ubiquitination and degradation
Human cells have a protein assembly called the proteasome, which specializes in degrading proteins. Ubiquitin is a small, highly soluble protein that is attached to other proteins as a signal. The proteasome only degrades proteins that are poly-ubiquitinated, i.e. are covalently linked to a linear chain of ubiquitins. The covalent link is between the amino group of a lysine side chain and the carboxylic acid of a glycine at the C-terminus of ubiquitin.
The deubiquitinase activity of Cdu1 stabilizes Mcl-1The deubiquitinase activity of Cdu1 stabilizes Mcl-1
The Chlamydia protein Cdu1 catalyzes the hydrolysis of ubiquitin chains from Mcl-1. When polyubiquitinated, Mcl-1 is destined to be degraded by the proteasome, lowering the level of Mcl-1 and subsequently leading to apoptosis. The activity of Cdub1 counteracts this by removing the ubiquitin, thus leading to higher levels of Mcl-1 in the cell.